Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ROCK2 | O75116 | 3/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | ROCK1 | Q13464 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 4/20 | 0.39 |
| ▸ | RAB9A | P51151 | 4/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | PPARG | P37231 | 2/20 | 0.39 |
| ▸ | NCOA2 | Q15596 | 2/20 | 0.39 |
| ▸ | NCOA1 | Q15788 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.39 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4525617 | 0.88 | ROCK2 (0.65) | ROCK2ROCK1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL4516227 | 0.88 | ROCK2 (0.65) | ROCK2ROCK1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL4517803 | 0.88 | ROCK2 (0.65) | ROCK2ROCK1NPC1RAB9ASMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL4504512 | 0.87 | ROCK2 (0.64) | ROCK2ROCK1NPC1RAB9ASMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL4514078 | 0.87 | ROCK2 (0.64) | ROCK2ROCK1NPC1RAB9ASMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL4521055 | 0.87 | ROCK2 (0.64) | ROCK2ROCK1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL4525361 | 0.80 | ROCK2 (0.52) | ROCK2 | |
| SCHEMBL4527225 | 0.77 | CIT (0.60) | ROCK2CYP1A2CYP3A4CYP2C19ROCK1 | |
| SCHEMBL4505598 | 0.77 | ROCK2 (0.51) | ROCK2CYP1A2CYP3A4CYP2C19ROCK1 | |
| SCHEMBL4516460 | 0.77 | ROCK2 (0.51) | ROCK2CYP1A2CYP3A4CYP2C19ROCK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090233960-A1 | Kinase Inhibitors | DEVGEN NV (BE) | 2009-09-17 | — | — | US | claimed |
| EP-1934181-A2 | KINASE INHIBITORS | Devgen NV (BE) | 2008-06-25 | — | — | EP | claimed |
| WO-2007042321-A2 | KINASE INHIBITORS | DEVGEN N.V. (BE) | 2007-04-19 | — | — | WO | claimed |
| US-20090233960-A1 | Kinase Inhibitors | DEVGEN NV (BE) | 2009-09-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090233960-A1 | Kinase Inhibitors | ROCK1, MAP3K1, MAP3K11 | ROCK2 32/4885CYP1A2 1743/4885CYP3A4 2235/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.